Analyst Ratings for ISIS Pharmaceuticals (isis)

isis Rating Summary

isis Price Target Summary

* Over Last 12-Mos
  |   Expand Research on isis
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $68.00 (+9.6%) * Over Last 12-Mos
Rating Score: 3.3 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
3/2/2015 Stifel Downgrade Hold
(Buy)
N/A
(66.00)
68.56 62.02 -9.54% Details
2/4/2015 Piper Jaffray Downgrade Neutral
(Overweight)
68.00
(81.00)
64.70 62.02 -4.14% Details
Like ISIS Ratings? Also take a look at SNY, SAN, BIIB, GSK

ISIS Ratings News